IDIBAPS, Institut d'Investigacions Biomèdiques August Pi i Sunyer

Resultats de l'any: 2010 2009 2008 2007

Factor d'impacte: mitjana: 6.05, total: 296.32

Articles de l'any 2010

Original

• Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation

  Timmermann L, Pauls KAM, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S
  BRAIN. 2010; 133: 701-712. IF: 9.49

• The decrease of beta-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

  Beyer K, Domingo-Sabat M, Santos C, Tolosa E, Ferrer I, Ariza A
  BRAIN. 2010; 133: 3724-3733. IF: 9.49

• Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study

  Stocchi F, Rascol O, Kieburtz K, Poewe W, Jankovic J, Tolosa E, Barone P, Lang AE, Olanow CW
  ANN NEUROL. 2010; 68: 18-27. IF: 9.317

• Mutation Update for the CSB/ERCC6 and CSA/ERCC8 Genes Involved in Cockayne Syndrome

  Laugel V, Dalloz C, Durand M, Sauvanaud F, Kristensen U, Vincent MC, Pasquier L, Odent S, Cormier-Daire V, Gener B, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, Heron D, Journel H, Raffo E, Vigneron J, Lyonnet S, Murday V, Gubser-Mercati D, Funalot B, Brueton L, DelPozo JS, Munoz E, Gennery AR, Salih M, Noruzinia M, Prescott K, Ramos L, Stark Z, Fieggen K, Chabrol B, Sarda P, Edery P, Bloch-Zupan A, Fawcett H, Pham D, Egly JM, Lehmann AR, Sarasin A, Dollfus H
  HUM MUTAT. 2010; 31: 113-126. IF: 6.887

• Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP

  Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Gomez-Isla T, Hernandez I, Lleo A, Machado A, Martinez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Perez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Sanchez-Valle R, Santana I, Tarraga L, Valdivieso F, Singleton A, Hardy J, Clarimon J
  NEUROBIOL AGING. 2010; 31: 725-731. IF: 5.937

• Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study

  Valldeoriola F, Regidor I, Minguez-Castellanos A, Lezcano E, Garcia-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Marti MJ, Martinez-Martin P, Relova L, Rumia J, Camara A, Burguera JA, Linazasoro G, DeVal JL, Obeso J, Rodriguez-Oroz MC, Tolosa E
  J NEUROL NEUROSUR PS. 2010; 81: 65-69. IF: 4.869

• Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

  Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, Tolosa E
  J NEUROL NEUROSUR PS. 2010; 81: 650-657. IF: 4.869

• Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein 1716F Mutation

  Guardia-Laguarta C, Pera M, Clarimon J, Molinuevo JL, Sanchez-Valle R, Llado A, Coma M, Gomez-Isla T, Blesa R, Ferrer I, Lleo A
  J NEUROPATH EXP NEUR. 2010; 69: 53-59. IF: 4.564

• Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease

  Bosch B, Batres-Faz D, Rami L, Arenaza-Urquijo EM, Fernandez-Espejo D, Junque C, Sole-Padulles C, Sanchez-Valle R, Bargallo N, Falcon C, Molinuevo JL
  CORTEX. 2010; 46: 451-461. IF: 4.058

• Nonlinear Dynamic Analysis of Oscillatory Repetitive Movements in Parkinson's Disease and Essential Tremor

  Costa J, Gonzalez HA, Valldeoriola F, Gaig C, Tolosa E, Valls-Sole J
  MOVEMENT DISORD. 2010; 25: 2577-2586. IF: 4.014

• Presentation, Diagnosis, and Management of Multiple System Atrophy in Europe: Final Analysis of the European Multiple System Atrophy Registry

  Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, DelSorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK
  MOVEMENT DISORD. 2010; 25: 2604-2612. IF: 4.014

• Olfactory Impairment in Parkinson's Disease and White Matter Abnormalities in Central Olfactory Areas: A Voxel-Based Diffusion Tensor Imaging Study

  Ibarretxe-Bilbao N, Junque C, Marti MJ, Valldeoriola F, Vendrell P, Bargallo N, Zarei M, Tolosa E
  MOVEMENT DISORD. 2010; 25: 1888-1894. IF: 4.014

• Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study

  Eggert K, Squillacote D, Barone P, Dodel R, Katzenschlager R, Emre M, Lees AJ, Rascol O, Poewe W, Tolosa E, Trenkwalder C, Onofrj M, Stocchi F, Nappi G, Kostic V, Potic J, Ruzicka E, Oertel W
  MOVEMENT DISORD. 2010; 25: 896-905. IF: 4.014

• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions

  VanDeerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DMA, Pickering-Brown SM, Seelaar H, Heutink P, VanSwieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, Ferrer I, Llado A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, DeMunain AL, Mckee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IRA, Feldman HH, Hamilton RL, Dekosky ST, VanDerZee J, Kumar-Singh S, VanBroeckhoven C, Mayeux R, Vonsattel JPG, Troncoso JC, Kril JJ, Kwok JBJ, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, Mclean CA, Decarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tunon MT, Martinez MCC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VMY
  NAT GENET. 2010; 42: 234-0. IF: 34.284

• Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers

  Fortea J, Sala-Llonch R, Bartres-Faz D, Bosch B, Llado A, Bargallo N, Molinuevo JL, Sanchez-Valle R
  J ALZHEIMERS DIS. 2010; 22: 909-922. IF: 3.832

• Greater Default-Mode Network Abnormalities Compared to High Order Visual Processing Systems in Amnestic Mild Cognitive Impairment: An Integrated Multi-Modal MRI Study

  Sala-Llonch R, Bosch B, Arenaza-Urquijo EM, Rami L, Bargallo N, Junque C, Molinuevo JL, Bartres-Faz D
  J ALZHEIMERS DIS. 2010; 22: 523-539. IF: 3.832

• Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder

  Iranzo A, Isetta V, Molinuevo JL, Serradell M, Navajas D, Farre R, Santamaria J
  SLEEP MED. 2010; 11: 534-539. IF: 3.699

• Late-stage Parkinson's disease: the Barcelona and Lisbon cohort

  Coelho M, Marti MJ, Tolosa E, Ferreira JJ, Valldeoriola F, Rosa M, Sampaio C
  J NEUROL. 2010; 257: 1524-1532. IF: 2.903

• Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment

  Sanchez-Benavides G, Gomez-Anson B, Quintana M, Vives Y, Manero RM, Sainz A, Blesa R, Molinuevo JL, Pena-Casanova J
  J INT NEUROPSYCH SOC. 2010; 16: 836-845. IF: 2.766

• A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression

  Llado A, Fortea J, Ojea T, Bosch B, Sanz P, Valls-Sole J, Clarimon J, Molinuevo JL, Sanchez-Valle R
  EUR J NEUROL. 2010; 17: 994-996. IF: 2.51

• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

  Iranzo A, Lomena F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavia J, Gallego J, Seppi K, Hogl B, Tolosa E, Poewe W, Santamaria J
  LANCET NEUROL. 2010; 9: 1070-1077. IF: 18.126

• Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

  Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladstrom A, Jones R
  LANCET NEUROL. 2010; 9: 969-977. IF: 18.126

• Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

  Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D
  LANCET NEUROL. 2010; 9: 573-580. IF: 18.126

• Medial Temporal Lobe Correlates of Memory Screening Measures in Normal Aging, MCI, and AD

  Sanchez-Benavides G, Gomez-Anson B, Molinuevo JL, Blesa R, Monte GC, Buschke H, Pena-Casanova J
  J GERIATR PSYCH NEUR. 2010; 23: 100-108. IF: 1.915

• The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease

  Rami L, Bosch B, Sanchez-Valle R, Molinuevo JL
  ARCH GERONTOL GERIAT. 2010; 50: 171-174. IF: 1.36

• Relearning vocabulary. A comparative analysis between a case of dementia and Alzheimer's disease with predominant compromise of language

  Montagut N, Sanchez-Valle R, Castellvi M, Rami L, Molinuevo JL
  REV NEUROLOGIA. 2010; 50: 152-156. IF: 1.234

• New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease

  Llado A, Sanchez-Valle R, Rey MJ, Mercadal P, Almenar C, Lopez-Villegas D, Fortea J, Molinuevo JL
  NEUROLOGIA. 2010; 25: 13-16. IF: 0.596

Revisió

• The role of DAT-SPECT in movement disorders

  Kagi G, Bhatia KP, Tolosa E
  J NEUROL NEUROSUR PS. 2010; 81: 5-12. IF: 4.869

• Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment

  Marin C, Obeso JA
  INT REV NEUROBIOL. 2010; 95: 191-205. IF: 4.017

• Missing pieces in the Parkinson's disease puzzle

  Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AHV, Halliday G
  NAT MED. 2010; 16: 653-661. IF: 27.136

• Focal limb dystonia

  Pont-Sunyer C, Marti MJ, Tolosa E
  EUR J NEUROL. 2010; 17: 22-27. IF: 2.51

• Intraduodenal infusion of levodopa

  Valldeoriola F, Camara A
  REV NEUROLOGIA. 2010; 51: 41-48. IF: 1.234

• Early diagnosis of Alzheimer's disease: the prodromal and preclinical phase

  Valls-Pedret C, Molinuevo JL, Rami L
  REV NEUROLOGIA. 2010; 51: 471-480. IF: 1.234

Editorials

• Cognition in essential tremor: should we worry about progressive cognitive decline?

  Tolosa E, Molinuevo JL
  EUR J NEUROL. 2010; 17: 1227-1228. IF: 2.51

Multicèntrics

• Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe

  Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, Demicco DA, Breazna A
  NEUROLOGY. 2010; 74: 956-964. IF: 8.172

• Motor Laterality Asymmetry and Nonmotor Symptoms in Parkinson's Disease

  Cubo E, Martin PM, Martin-Gonzalez JA, Rodriguez-Blazquez C, Kulisevsky J
  MOVEMENT DISORD. 2010; 25: 70-75. IF: 4.014

• Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis

  Forjaz MJ, Ayala A, Rodriguez-Blazquez C, Frades-Payo B, Martinez-Martin P
  EUR J NEUROL. 2010; 17: 273-279. IF: 2.51

• What contributes to driving ability in Parkinson's disease

  Cubo E, Martin PM, Gonzalez M, Bergareche A, Campos V, Fernandez JM, Alvarez M, Bayes A, RODRIGUEZ-BALZQUEZ
  DISABIL REHABIL. 2010; 32: 374-378. IF: 1.555

Tornar